Caplight Directory>Companies>Endura Therapeutics-preview>Enduratx


Endura Therapeutics

Endura Therapeutics

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://enduratx.com/

Last Round

Grant

May 15, 2025

Company Overview

Endura Therapeutics is a biotechnology company developing a platform for small molecule drug discovery that targets RNA to create treatments for diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Application

Keywords

RNA-targeting small moleculessmall molecule drug discoverydrug discovery platformundruggable targetsAI drug discoverycovalent drug discoverymRNA targetingAI-native biotechnext-generation sequencingNGSchemo-genomicspreclinical biotechnologySmall Business Innovation ResearchSBIR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Endura Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Endura Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantMay 15, 2025
SeedSep 6, 2024
View all Funding Rounds

Endura Therapeutics Investors

Notable investors and investment history

InvestorRounds
Scribble VenturesSeed
Calm VenturesSeed
SciFoundersSeed
National Science FoundationSeed, Grant
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2025

    $303K grant received from the National Science Foundation.

  • Sep 6, 2024

    Raised capital from Calm Ventures, SciFounders, Scribble Ventures, and NSF.

View all signals

Endura Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Endura Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Endura Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Year Founded2024
Last FundingMay 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.